IQVIA Holdings Inc. (XETRA: QTS) Stock Analysis & Fundamentals

QTSIQVIA Holdings Inc.

XETRA · DE · Healthcare · Diagnostics & Research · iqvia.com

220.80EUR-0.41%Mkt Cap: 39.67B $P/E: 31.901d ago

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates …

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

IDEXX Laboratories, Inc.

$44.35BUSDP/E 39.5

Agilent Technologies, Inc.

Mettler-Toledo International, Inc.

$28.55BUSDP/E 32.1

Labcorp Holdings Inc.

$26.80BUSDP/E 27.4

DGX

Quest Diagnostics Incorporated

$26.68BUSDP/E 25.6

Guardant Health, Inc.

$21.92BUSD

MEDP

Medpace Holdings, Inc.

$16.98BUSDP/E 35.8

ERF

Eurofins Scientific SE

$13.64BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$13.84BUSD

RVTY

Revvity Inc. Common Stock

Twist Bioscience Corp.

$8.93BUSD

Key Statistics

Company

Market Cap39.67B $

Enterprise Value53.07B $

Revenue (TTM)18.46B $

Gross Profit5.90B $

Net Income (TTM)1.48B $

Revenue/Share109.46 USD

Last Price220.80 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees94.0K

CountryDE

SectorHealthcare

IndustryDiagnostics & Research

ISINUS46266C1053

Valuation

P/E (Trailing)31.90

P/E (Forward)—

PEG0.98

EV/EBITDA16.02

EV/Revenue2.87

P/S2.03

P/B6.47

EPS (TTM)6.95

EPS (Forward)—

52W Range

209.7093% of range221.70

52W High221.70 EUR

52W Low209.70 EUR

Profitability

Gross Margin33.29%

Oper. Margin13.03%

EBITDA Margin17.95%

Profit Margin8.34%

ROE20.91%

ROA4.54%

Growth

Revenue Growth8.70%

Earnings Growth-0.60%

Cash Flow & Leverage

Operating CF2.88B $

CapEx (TTM)655.43M $

FCF Margin12.66%

FCF Yield5.89%

Net Debt15.41B $

Net Debt/EBITDA4.65

Balance Sheet

Debt/Equity2.45

Current Ratio0.71

Quick Ratio0.62

Book Value/Sh32.43 EUR

Cash/Share12.64 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 EUR

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.164.60M

Float156.25M

Insiders1.09%

Institutions103.46%

Technical

SMA 50176.25 (+25.3%)

SMA 200176.77 (+24.9%)

Beta1.18

S&P 52W Chg20.80%

Avg Vol (30d)52

Avg Vol (10d)9

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—